Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde Skuterud Wik

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Thrombosis and Haemostasis|June 30, 2019
Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous ThrombosisAnders E A Dahm, Eva Marie Jacobsen, Hilde Skuterud Wik, et al.
Research and Practice in Thrombosis and Haemostasis|May 4, 2026
Item generation for a new disease-specific health-related quality of life questionnaire in patients with deep vein thrombosis: an international multicenter studyElia Asady, Lars-Petter Jelsness-Jorgensen, Waleed Ghanima, et al.
European Journal of Haematology|January 9, 2024
Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosisMirjam Podgorica, Elsa Drivet, Jonas Krag Viken, et al.
Targeted Oncology|September 8, 2025
Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric PatientsTianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann, et al.
Frontiers in Oncology|February 11, 2025
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolismMarte Svalastoga, Trine-Lise Larsen, Jorunn Brekke, et al.
Thrombosis Research|September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolismTrine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Journal of Thrombosis and Haemostasis : JTH|July 21, 2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": ReplyTrine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Journal of Thrombosis and Haemostasis : JTH|February 3, 2022
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-upTrine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Thrombosis Research|June 16, 2023
Arterial events in cancer patients treated with apixaban for venous thrombosisTrine-Lise Larsen, Marte Svalastoga, Jorunn Brekke, et al.
Leukemia|January 29, 2024
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemiaMerete Dam, Maddalena Centanni, Lena E Friberg, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Thrombosis and Haemostasis|June 30, 2019
Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous ThrombosisAnders E A Dahm, Eva Marie Jacobsen, Hilde Skuterud Wik, et al.
Research and Practice in Thrombosis and Haemostasis|May 4, 2026
Item generation for a new disease-specific health-related quality of life questionnaire in patients with deep vein thrombosis: an international multicenter studyElia Asady, Lars-Petter Jelsness-Jorgensen, Waleed Ghanima, et al.
European Journal of Haematology|January 9, 2024
Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosisMirjam Podgorica, Elsa Drivet, Jonas Krag Viken, et al.
Targeted Oncology|September 8, 2025
Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric PatientsTianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann, et al.
Frontiers in Oncology|February 11, 2025
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolismMarte Svalastoga, Trine-Lise Larsen, Jorunn Brekke, et al.
Thrombosis Research|September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolismTrine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Journal of Thrombosis and Haemostasis : JTH|July 21, 2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": ReplyTrine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Journal of Thrombosis and Haemostasis : JTH|February 3, 2022
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-upTrine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Thrombosis Research|June 16, 2023
Arterial events in cancer patients treated with apixaban for venous thrombosisTrine-Lise Larsen, Marte Svalastoga, Jorunn Brekke, et al.
Leukemia|January 29, 2024
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemiaMerete Dam, Maddalena Centanni, Lena E Friberg, et al.
Pageof 4